switching between glp-1 agonists ada Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance GLP-1 RA education

Minerva Endocrinol (2021) 46:16876

FDA guidance should help distinguish between noncompliant and clinically justified compounded formulations, supporting prescribers who have legitimate reasons for seeking tailored options

Constipation rates are comparable to semaglutide, but tirzepatide users often report more intense initial gastrointestinal symptoms that tend to resolve more quickly as the medication takes effect

62 Different ligands lead to different interaction patterns with the receptor, generating various effects

Because it provides a constant level of insulin regardless of blood sugar status, blood glucose can drop dangerously low if a patient skips meals, exercises vigorously, or takes too much insulin